News Daily News Weight Loss Drugs Show Promise for Secondary Prevention in PAD L.A. McKeown February 04, 2026
News Daily News Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass Yael L. Maxwell January 14, 2026
News Daily News JACC Debuts Data Digest on CV Health in the United States Caitlin E. Cox January 12, 2026
News Daily News Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News Todd Neale December 26, 2025
News Daily News Fish Oil Halves CV Risk in Patients on Dialysis: PISCES Yael L. Maxwell November 10, 2025
News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
Presentation TCT 2025 TCT 484: Artificial Intelligence for prediction of Amputations in Diabetic Foot Ulcers: A Systematic Review and Meta-analysis Presenter: Rahul Ravindra October 27, 2025
News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Daily News POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies L.A. McKeown July 15, 2025
News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK L.A. McKeown April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Daily News Survey Calls Out Implicit Bias in Peripheral Vascular Care L.A. McKeown February 28, 2025
News Daily News Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many L.A. McKeown January 16, 2025
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News VIVA 2024 Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care L.A. McKeown November 07, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024